El Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 Welcomes project leaders, procurement specialists, and technical professionals from across the value chain. On April 20 and 21 in Amsterdam, the Congress will address evolving trends in the pharmaceutical industry: sustainable packaging solutions, anti-counterfeiting policies, and more.
Following a memorable anniversary, PHARMAP 2026 It is preparing to move into its next phase, fostering a wave of networking, B2B collaborations, and real-world case studies. The sixth edition of the Congress delves into the practical applications of personalized medicine in production and presents innovative strategies for adopting Pharmacy 4.0, addressing the emerging challenges of the pharmaceutical industry.
In 2026, the SCHEDULE The business section highlights key industry topics, including secure packaging solutions, sustainable manufacturing practices, and smart supply chain innovations. Exploring these topics empowers companies to transition to more efficient and impactful strategies. Rocco Paracchini, Commercial Director of Doppel Pharma CDMO, shared her opinion: “it’s a good combination of presentations, which gives the audience the opportunity to interact with the presenters.”
PHARMAP 2026 It promotes a greener future for the sector by facilitating collaboration with suppliers to implement environmentally friendly practices, improve energy efficiency in production facilities, and implement innovations for eco-efficient manufacturing.
“We had a very interesting and in-depth debate at my round table: others have the same problems and we can try to find a common solution,” he commented. Meriem Loudiyi, Director of the Trademark and Anti-Counterfeiting Department at Laboratoires Servier, following its presentation last year.
La calendar The next PHARMAP includes information on:
● High-tech packaging solutions, using smart and digital technologies to improve user experience and supply chain efficiency.
● Digitalization of pharmaceutical manufacturing through robotic solutions and artificial intelligence (AI).
● Establishment of robust quality control systems in the contracted facilities.
● Transparency in pharmaceutical supply chains through collaborations between pharmaceutical companies and suppliers, blockchain, IoT and AI.
● Patient-centered product design and packaging strategies.
● Measures to combat the illegal production of counterfeit medicines.
The Congress offers participants the opportunity to gain valuable insights from detailed case studies presented by industry leaders such as Bayer, Innowise, Belupo, Esteve, among others, paving the way for significant innovation in the pharmaceutical sector.
Be part of the change: https://sh.bgs.group/3l4
